Melanoma Research

Article	Citations
Genetic concordance in melanoma: insights from primary tumors and their matched distant metastases	28
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?	20
Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel	20
Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread	19
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors	18
Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases	17
Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines	15
Clinicopathological demographics of malignant melanomas of the vulva and vagina in Japan	13
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting	13
Rurality as a predictor of melanoma stage and treatment in Indiana: a retrospective cohort study	13
Brain metastases during follow-up of patients with resected cutaneous melanoma	12
The potential of using artificial intelligence to improve skin cancer diagnoses in Hawai‘i’s multiethnic population	12
Do cortisol and psychological distress levels impact the effectiveness of immunotherapy in patients with metastasized melanoma? A pilot study	12
Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model	11
Study of clinical characteristics and risk factors for amelanotic/hypomelanotic melanoma in an Australian cohort	11
Pretreatment CD8+PD-1+ to CD4+PD-1+ ratio is associated with the prognosis of advanced melanoma patients treated with PD-1 inhibitors	10
Cytomegalovirus gastritis as a rare adverse event during combined ipilimumab and nivolumab in a patient with melanoma	10
Assessment of lipid and pigment content in suspicious melanocytic lesions to improve melanoma detection	10
Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis: Erratum	10
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy	10
Relationships between survival and real-world recurrence-free survival or distant metastasis-free survival among patients with completely resected stage IIB or IIC melanoma	9
Challenging pigmented lesions in melanoma patients during checkpoint-inhibitors therapy	9
Clinical and dermoscopical presentation of nivolumab-induced pemphigoid in a metastatic melanoma patient	9
Diagnostic and prognostic value of Beclin 1 expression in melanoma: a meta-analysis	9
Regular use of vitamin D supplement is associated with fewer melanoma cases compared to non-use: a cross-sectional study in 498 adult subjects at risk of skin cancers	8

Immunotherapy-induced granulomatous reaction in patients with melanoma	8
Diffuse large B-cell lymphoma mimicking metastatic melanoma: the importance of biopsies in the era of immune checkpoint inhibitors	8
Immunotherapy for treatment of female genital tract melanoma: National Cancer Database analysis	8
Association of baseline neutrophil-to-lymphocyte ratio and prognosis in melanoma patients treated with PD-1/PD-L1 blockade: a systematic review and meta-analysis	8
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma	8
Ultraviolet A radiation exposure and melanoma: a review	8
Electrical impedance spectroscopy significantly enhances correct biopsy choice for pigmented skin lesions beyond clinical evaluation and dermoscopy	8
LINC01063 functions as an oncogene in melanoma through regulation of miR-5194-mediated SOX12 expression	7
GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients	7
Uncomplicated pregnancy and delivery under ongoing nivolumab therapy for metastatic melanoma	7
Updated meta-analysis on the risk of melanoma associated with phosphodiesterase type 5 inhibitors	7
Temporal correlation between the first melanoma and the first noncutaneous tumor in CKDN2A genotyped patients	7
Postimmunotherapy antiglial fibrillary acidic protein encephalomyelitis after adjuvant pembrolizumab for melanoma	7
Interfering with aggregated α-synuclein in advanced melanoma leads to a major upregulation of MHC class II proteins	6
Neurologic adverse events associated with BRAF and MEK inhibitor therapy in patients with malignant melanoma: a disproportionality analysis using the Food and Drug Administration Adverse Event Reporti	6
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series	6
Programmed death ligand-1 PET imaging in patients with melanoma: a pilot study	6
Clostridium difficile infection and immune checkpoint inhibitor–induced colitis in melanoma: 18 cases and a review of the literature	6
Hemophagocytic lymphohistiocytosis induced by dabrafenib-trametinib in a patient with metastatic melanoma: a case report and pharmacovigilance analysis	6
Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases	6
Multiple melanoma, ichthyosis, and juvenile cataracts in a patient with a germline mutation in CDKN2A: pure coincidence or related association?	6
Documenting the histologic response of metastatic melanoma to combination therapy with BRAF and MEK inhibitors	6
Exacerbation of Kaposi sarcoma following BRAF/MEK inhibitor therapy in a melanoma patient: a case report and mechanistic insight	6
The effect of microRNA-9 overexpression on inhibition of melanoma cancer stem cells tumorigenicity	6
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma	5
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma	5
Intratumoural and systemic inflammation as predictors for treatment response in BRAF-mutated melanoma patients under targeted therapies	5
Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition	5
Resolution of diffuse cuticular melanosis under immunotherapy in a patient with metastatic melanoma	5
Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients	5
Evaluation of surgical modalities for stage 0 to stage II acral lentiginous melanoma: a National Cancer Database study	5
Exceptional response to combination ipilimumab and nivolumab in metastatic uveal melanoma: Insights from genomic analysis	5
Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment	5
Simultaneous melanomas in the setting of multiple primary melanomas	5
Impact of systemic imaging surveillance on survival from metastatic uveal melanoma	5
Variance from published guidelines and changes in temporal trends in the management of cutaneous malignant melanoma: a 5-year update	5
Efficacy and safety of angiogenesis inhibitors in melanoma: a meta-analysis of seven randomized controlled trials	5
Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety	5
DNA methylation of GITR, OX40, 4-1BB, CD27, and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma	4
The human and animals’ malignant melanoma: comparative tumor models and the role of microbiome in dogs and humans	4
Identification of heterogeneity and prognostic key genes associated with uveal melanoma using single-cell RNA-sequencing technology	4
Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma	4
Melanoma risk during immunomodulating treatment	4
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors	4
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era	4
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients	4
The immunologic balance: three cases of rituximab-associated melanoma	4
Melanoma and pregnant women: a systematic review and meta-analysis	4
Molecular profiling of primary uveal melanoma: results of a Polish cohort	4
Intracranial hemorrhage caused by dabrafenib and trametinib therapy for metastatic melanoma	4

Melanoma in the head and neck region: the value of preoperative imaging in melanoma stage I–II	4
Ultra-high-frequency ultrasound monitoring of melanomas arising in congenital melanocytic nevi: a case series	4
Successful use of rituximab for refractory hemophagocytic lymphohistiocytosis in a melanoma patient treated with targeted therapy	4
First-time office visit for suspicious skin lesion evaluation as a predictor of high-risk melanoma	3
Lower melanoma pulmonary metastatic burden in obese mice: role of FGF-21	3
Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practice	3
Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma	3
Assessing melanoma prognosis: the interplay between patient profiles, survival, and BRAF, NRAS, KIT, and TWT mutations in a retrospective multi-study analysis	3
Upregulation of SFTPC gene expression is associated with disease progression and worse survival outcomes in human skin melanomas	3
Survival in adult patients with BRAFV600 mutation-positive advanced melanoma: a noninterventional ambispective study of patients with cobimetinib combined with vemurafenib during the French early acce	3
Correlations between inflammatory cytokine levels and degree of pigmentation in acral melanomas	3
Management of heterogeneous tumor response patterns to immunotherapy in patients with metastatic melanoma	3
Reflectance confocal microscopy versus dermoscopy for the diagnosis of cutaneous melanoma: a head-to-head comparative meta-analysis	3
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma	3
Neonatal cutaneous melanoma with cutaneous metastasis: a case report and review of literature	3
A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors	3
A retrospective study of clinicopathological and prognostic characteristics in 177 Chinese patients with acral melanoma: heterogeneity based on tumor site	3
Leptomeningeal dissemination as a first sign of progression in metastatic melanoma: a diagnostic lesson	3
Combined PDE4+MEK inhibition shows antiproliferative effects in NRAS Q61 mutated melanoma preclinical models	3
Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis	2
Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases	2
The effect of COVID-19 on early melanoma detection	2
Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020	2
BRCA1-associated protein 1 c.368delG mutation leads to the development of multiple BAPomas and cutaneous melanomas: a novel pathogenic variant in BRCA1-associated protein tumor predisposition syndrome	2
Diagnosis and management of concurrent metastatic melanoma and chronic myelomonocytic leukemia	2
Open-label nonrandomized phase IB study to characterize the safety and recommended dose of tinostamustine in combination with nivolumab in patients with advanced melanoma (ENIgMA)	2
ATF3 regulates CDC42 transcription and influences cytoskeleton remodeling, thus inhibiting the proliferation, migration and invasion of malignant skin melanoma cells	2
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma	2
The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy	2
Prognostic significance of tumor budding in melanoma	2
Safety of combining dabrafenib plus trametinib in elderly BRAF V600 mutation-positive advanced melanoma patients: real-world data analysis of Spanish patients (ELDERLYMEL)	2
Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies	2
Psychosocial wellbeing in people with melanoma in-situ: a systematic review	2
Expect the unexpected: a saying to bear in mind	2
Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma	2
Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort study	2
Patient-reported outcomes in randomized controlled trials evaluating BRAF inhibitors in patients with cutaneous melanoma: a systematic scoping review of quality of reporting and trial results	2
LS-007 inhibits melanoma growth via inducing apoptosis and cell cycle arrest and regulating macrophage polarization	2
Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients	2
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma	2
Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective	2
Polymorphisms in toll-like receptor 3 and 4 genes as prognostic and outcome biomarkers in melanoma patients	2
Improved cutaneous melanoma survival stratification through integration of 31-gene expression profile testing with the American Joint Committee on Cancer 8th Edition Staging	2
The death rate for melanoma remained unchanged in the USA during the coronavirus disease 2019 pandemic	2
Noncontrast-enhanced 3-Tesla MRI using surface coil as a complementary test for assessment of distribution and depth of locoregional cutaneous metastases of malignant melanoma	2
Talimogene laherparepvec monotherapy for head and neck melanoma patients	2
Direct early growth response-1 knockdown decreases melanoma viability independent of mitogen-activated extracellular signal-related kinase inhibition	2
Nomograms versus artificial intelligence platforms: which one can better predict sentinel node positivity in melanoma patients?	2
Eruptive melanocytic nevi in a patient with amelanotic melanoma: a paraneoplastic phenomenon?	2
Impact of gene expression profiling on diagnosis and survival after metastasis in patients with uveal melanoma	2
Dermatologic surveillance in healthy carriers of CDKN2A and p.E318K MITF germline variants from melanoma-prone families: a 14 years hospital-based experience	2
Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy	2
Vitiligo-like hypopigmentation secondary to adjuvant checkpoint inhibitor therapy in patients with resectable stage III melanoma: a cohort from two tertiary hospitals	2
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma	2
Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors	2
Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma	2
Relation between dabrafenib plus trametinib-induced pyrexia and age in BRAF V600-mutated metastatic melanoma patients: A post hoc analysis of the real-world ELDERLYMEL study	2
High-resolution RNA-sequencing reveals TRIM33::CSDE1 gene fusion in metastasizing vulvar melanoma	2
Efficacy of local ablative therapies in patients with solid tumors treated with immune checkpoint inhibitors and oligoprogression: a single-center analysis	2
Female melanoma and estrogen receptors expression: an immunohistochemical pilot study	2
Retrospective comparison of a weight-based dose every 2 weeks with a fixed dose every month: a real-life analysis of nivolumab in the treatment of advanced melanoma	2
Survivals following discontinuation of PD-1 inhibitor treatment in advanced melanoma patients	2
Uveal melanoma metastatic at initial diagnosis: a case series	2
Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanoma	2
Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case series	2
Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma	1
pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma	1
Cardiovascular disease and malignant melanoma	1
Transcutaneous sentinel lymph node detection in skin melanoma with near-infrared fluorescence imaging using indocyanine green	1
Development and validation of prognostic nomogram in pediatric melanoma: a population-based study	1
Response of metastatic melanoma with a rare BRAF V600K mutation to dabrafenib and trametinib	1
Phase II study of apatinib combined with temozolomide in patients with advanced melanoma after failure of immunotherapy	1
Nivolumab-induced immune-mediated acute gastritis in a melanoma patient	1
Steroid-refractory severe immune-related mucositis following adjuvant anti-PD-1 therapy for resectable melanoma: a case report	1
The role of wide local excision of a primary lesion in cutaneous malignant melanoma: a retrospective analysis of its usefulness in local and general control of disease	1
Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients	1
Perioperative neutrophil-to-lymphocyte ratio in patients with melanoma: a pilot study assessing surgical stress after sentinel lymph node biopsy	1
Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-int	1
Thrombospondin 2 drives liver metastasis in skin cutaneous melanoma via regulation of angiogenesis and extracellular matrix remodeling	1
Fertility preservation for patients with melanoma	1

The inhibitory role of microRNA-141-3p in human cutaneous melanoma growth and metastasis through the fibroblast growth factor 13-mediated mitogen-activated protein kinase axis	1
Quality of life after melphalan percutaneous hepatic perfusion for patients with metastatic uveal melanoma	1
Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis	1
Compound 48/80 suppresses melanoma growth by inducing apoptosis and enhancing immune response	1
Clinical response under MEK inhibitor alone in metastatic melanoma with a novel fusion involving the RAF1 gene	1
Pembrolizumab-induced acquired lipodystrophy: a case report and review of the literature	1
The role of artificial intelligence and convolutional neural networks in the management of melanoma: a clinical, pathological, and radiological perspective	1
Real-world relapse-free survival data on adjuvant anti-PD-1 therapy for patients with newly diagnosed and recurrent stage III melanoma	1
Description of supportive care and feasibility of physical exercise program to improve quality of life in advanced melanoma patients	1
Circulating tumor DNA predicts tumor progression and poor survival in patients with stage III melanoma	1
Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea	1
Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1	1
Cost-effectiveness analysis of an orphan drug tebentafusp in patients with metastatic uveal melanoma and a call for value-based pricing	1
Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma: Erratum	1
Successful use of nivolumab and relatlimab as salvage therapy for metastatic uveal melanoma	1
Macrophage inhibitory cytokine-1 produced by melanoma cells contributes to melanoma tumor growth and metastasis in vivo by enhancing tumor vascularization	1
Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s)	1
Integrating neutrophils, lymphocytes and eosinophils: development and validation of the NLE Index in ICI-treated metastatic melanoma	1
A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio	1
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort	1
Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy	1
New technique for in-continuity axillary and supraclavicular lymphadenectomy for advanced metastatic melanoma using intraoperative image guidance: a case report	1
Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients	1
Regorafenib in patients with pretreated advanced melanoma: a single-center case series	1
Literature case analysis of immune checkpoint inhibitors-associated lipodystrophy	1
Targeting cyclin-dependent kinase 4/6 as a therapeutic approach for mucosal melanoma	1
Melanoma cell plasticity poses diagnostic challenges: a case series	1
Underreporting of acral lentiginous melanoma in studies informing American Joint Committee on Cancer Staging System Guidelines: a review of 150 cited studies	1
Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia: a case series and	1
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience	1
Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report	1
Preoperative assessment of cutaneous melanoma thickness by multispectral dermoscopy	1
Effectiveness and safety of talimogene laherparepvec and granulocyte-macrophage colony-stimulating factor for metastatic melanoma: a systematic review and network meta-analysis of randomized controlle	1
Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma	1
Treatment outcomes following partial shave biopsy of atypical and malignant melanocytic tumors in pediatric patients	1
Vitamin D deficiency in melanoma patients is associated with worse overall survival: a retrospective cohort study	1
Tocilizumab in the treatment of steroid refractory immune-related hepatotoxicity: a case series and review of the literature	1
Total body skin examination visits by dermatology providers in the 2011–2016 National Ambulatory Medical Care Survey	1
A survey of skin check rates in an outpatient oncology melanoma clinic	1
Tumour regression predicts better response to interferon therapy in melanoma patients: a retrospective single centre study	1
Hypoxic transcriptomes predict survival and tumor-infiltrating immune cell composition in cutaneous melanoma	1
Use of laboratory hematology data in melanoma research: comments on “A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio” Melanoma Res	1
The association between dermatologist density and melanoma prognosis using melanoma mortality-incidence ratio	1
Prognosis of polypoid melanoma: a comparative study with non-polypoid melanomas	1
Melanoma risk prediction based on a polygenic risk score and clinical risk factors	1
Novel strategy for applying hierarchical density-based spatial clustering of applications with noise towards spectroscopic analysis and detection of melanocytic lesions	1
CD103 and periplakin are potential biomarkers for response of metastatic melanoma to pembrolizumab	1